LoginSign Up
Bioeconomy Capital

Bioeconomy Capital

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Investments

Timeline

Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

People

Name
Role
Related Golden topics

Rik Wehbring

Founder & managing director (San Francisco)

Rob Carlson

Founder & managing director (Seattle)

Further reading

Author
Title
Link
Type

Benjamin Romano

Xconomy: Seattle Area Had a Middling 2017 for Venture Investment, Fundraising

News article

BIOCOM AG

GBS 2018: Bioeconomy leaders foster shift to sustainable industry production

News article

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References